Trends in malignant melanoma mortality in 31 countries from 1985 to 2015

被引:43
|
作者
Yang, D. D. [1 ]
Salciccioli, J. D. [3 ]
Marshall, D. C. [4 ]
Sheri, A. [2 ]
Shalhoub, J. [5 ]
机构
[1] Royal Free London NHS Fdn Trust, North Cent & East London Fdn Sch, London, England
[2] Royal Free London NHS Fdn Trust, Dept Oncol, London, England
[3] Harvard Med Sch, Mt Auburn Hosp, Dept Med, Cambridge, MA USA
[4] Univ Oxford, Nuffield Dept Clin Neurosci, Crit Care Res Grp, Oxford, England
[5] Imperial Coll London, Dept Surg & Canc, Acad Sect Vasc Surg, London, England
关键词
SKIN-CANCER PREVENTION; EUROPE; SURVIVAL; DISEASE; RISK; DIET; EUROMELANOMA; IPILIMUMAB; AUSTRALIA; EXPOSURE;
D O I
10.1111/bjd.19010
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Malignant melanoma (MM) causes the highest absolute number of deaths among skin cancers. An up-to-date analysis of international MM mortality trends is required for assessing the burden of disease, and may support the assessment of the effectiveness of new diagnostic, therapeutic and preventative strategies. Objectives To report MM mortality trends between 1985 and 2015 using the World Health Organization (WHO) Mortality Database. Materials and methods We used country-level MM mortality data from the WHO Mortality Database for all countries with high usability death registration data. Mortality trends were described using Joinpoint regression modelling. Results Thirty-one countries met the inclusion criteria. All countries, except the Czech Republic, demonstrated increased age-standardized death rates (ASDRs) in males over the observation period. More countries exhibited decreased or stable MM mortality in females. The median mortality rate for 2013-2015 was 2 center dot 57 deaths per 100 000 for males and 1 center dot 55 per 100 000 for females. Australia and Norway had the highest ASDRs for males (5 center dot 72 per 100 000 and 4 center dot 55 per 100 000, respectively). Norway and Slovenia had the highest ASDRs for females (3 center dot 02 per 100 000 and 2 center dot 58 per 100 000, respectively). MM mortality was greater for males than females in all countries, with sex disparity increasing across the period. Disparity in mortality between older and younger cohorts in several countries was also found. Conclusions An overall increase in MM mortality over the past 30 years was observed. However, there was notable variation in mortality trends between countries, as well as between males and females, and between different age groups. What is already known about this topic? Malignant melanoma (MM) has the highest mortality among skin cancers. The majority of MM cases can be attributed to known, modifiable risk factors. The incidence of MM is reported to have increased over past decades in many regions, but recent signs of stabilization and decline in MM incidence and mortality have also been reported in some regions. What does this study add? MM mortality trends across a large number of different populations over the past 30 years were studied. An overall increase in MM mortality was observed. All countries except one demonstrated increased age-standardized death rates in males, while more countries exhibited decreased or stable MM mortality in females. MM mortality was greater in males than in females in all countries, with sex disparity increasing across the period.
引用
收藏
页码:1056 / 1064
页数:9
相关论文
共 50 条
  • [41] Cutaneous malignant melanoma mortality in Spain from 1979 to 2018. Trends and new perspectives in the immunotherapy era
    Duran-Romero, A. J.
    Sendin-Martin, M.
    Conejo-Mir, J.
    Pereyra-Rodriguez, J. J.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (04) : 884 - 891
  • [42] Trends in Avoidable Mortality in Kazakhstan From 2015 to 2021
    Kosherbayeva, Lyazzat
    Akhtayeva, Nazgul
    Tolganbayeva, Kamshat
    Samambayeva, Aizhan
    [J]. INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, 2024, 13
  • [43] TRENDS IN MELANOMA INCIDENCE AND MORTALITY
    LEE, JAH
    [J]. CLINICS IN DERMATOLOGY, 1992, 10 (01) : 9 - 13
  • [44] STRATEGIES TO REDUCE MORTALITY FROM CUTANEOUS MALIGNANT-MELANOMA
    MACKIE, RM
    [J]. ARCHIVES OF DERMATOLOGICAL RESEARCH, 1994, 287 (01) : 13 - 15
  • [45] Mortality from malignant melanoma in Chile, 1986-95
    Zemelman, V
    Kirschbaum, A
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1998, 139 (06) : 1111 - 1112
  • [46] TRENDS IN MORTALITY-RATE FROM MALIGNANT SKIN MELANOMA AND OTHER MALIGNANT SKIN NEOPLASMS IN CZECHOSLOVAKIA DURING PERIOD 1921-1970
    SOMOGYI, J
    HOSTYNOVA, E
    SIMKOVIC, D
    [J]. NEOPLASMA, 1976, 23 (06) : 667 - 675
  • [47] INTERNATIONAL TRENDS IN ASTHMA MORTALITY - 1970 TO 1985
    JACKSON, R
    SEARS, MR
    BEAGLEHOLE, R
    REA, HH
    [J]. CHEST, 1988, 94 (05) : 914 - 918
  • [48] TRENDS IN IMMUNOTHERAPY OF MALIGNANT-MELANOMA
    TRITSCH, H
    [J]. HAUTARZT, 1976, 27 (01): : 1 - 7
  • [49] Trends in malignant melanoma epidemiology in Devon
    Frost, T
    Warin, AP
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 : 35 - 35
  • [50] Current trends in the treatment of malignant melanoma
    Valko-Rokytovska, M.
    Bruchata, K.
    Simkova, J.
    Milkovicova, M.
    Kostecka, Z.
    [J]. NEOPLASMA, 2016, 63 (03) : 333 - 341